Family Practice Advance Access originally published online on August 28, 2007
Family Practice 2007 24(4):293-294; doi:10.1093/fampra/cmm054
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.
Editorial |
Economic analysis and complex randomized controlled trials
Editor, Family Practice, Professor of Primary Care, The University of Birmingham, Primary Care Clinical Sciences Building, Edgbaston, Birmingham B15 2TT, UK
Email: b.c.delaney@bham.ac.uk
| The first 10% of the full text of this article appears below. |
Historically many health care interventions outside therapeutics have been applied without formal evaluation, as they seemed appropriate. This has been partly as the political imperatives of healthcare reforms have promoted change before evaluation, examples being numerous in the UK National Health Service. However, the evaluation of the complex intervention that inevitably ensues when we change who by or how treatments are carried out is challenging indeed. About 10 years ago the UK Medical Research Council published a framework for the evaluation of complex interventions.1 The framework emphasized the necessary theoretical groundwork to develop an intervention adequately before testing it, yet funders